There has been an alarming worldwide increase in Streptococcus pneumon
iae resistance to antibiotics, particularly penicillin, in recent year
s. It is in children, particularly those with acute otitis media (AOM)
, that the highest frequency of resistance is observed. S. pneumoniae
is the main isolate in AOM, and otitis is the most frequent childhood
pneumococcal infection. An epidemiologic surveillance network has been
set up to monitor the involvement of PR S. pneumoniae in AOM treatmen
t failures in Paris area. A total of 293 children presenting to 12 ear
, nose and throat (ENT) specialists were included in the study. Bacter
iological sampling demonstrated that in 146 cases (49,8%), no pathogen
was present at the time of treatment failure. In the remaining patien
ts S. pneumoniae was the most frequently recovered pathogen, being iso
lated from 81/147 (55,1%) of bacteriologically documented cases. Serot
ype 23F was the predominant strain, representing 53% of all S. pneumon
iae isolates recovered. Resistance or reduced susceptibility to the pr
escribed antibiotic was seen in 70/81 (86,4%) of the S. pneumoniae iso
lates. Amoxycillin seemed to be the most active oral beta-lactam again
st these pathogens. It seems to exist a correlation between low serum
inhibitory quotient and failures. The multiresistance of S. pneumoniae
poses a serious therapeutic problem and should make myringotomy and b
acteriological sampling obligatory in cases of antibiotic treatment fa
ilure.